On November 17, 2023, Harry S. Palmin, Chief Financial Officer, ceased to be an executive officer of Acer Therapeutics Inc.
Acer Therapeutics Inc.
Equities
ACER
US00444P1084
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |